stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Gross margin
Integer Holdings Corporation's gross margin over the twelve months to 30 September 2026 was 24.6%, down 2.4 percentage points from fiscal 2025 (27.0%). Over the past ten years it has ranged from 26.0% (fiscal 2022) to 31.4% (fiscal 2016); the current reading is higher than 45% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 27.0% | 0.25 |
| FY2024 | 26.7% | 0.39 |
| FY2023 | 26.4% | 0.38 |
| FY2022 | 26.0% | (1.63) |
| FY2021 | 27.6% | 0.98 |
| FY2020 | 26.6% | (1.60) |
| FY2019 | 28.2% | (1.63) |
| FY2018 | 29.9% | (1.31) |
| FY2017 | 31.2% | (0.24) |
| FY2016 | 31.4% | 2.02 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 22.6% | (1.75) |
| Jun 2026 | 24.3% | (0.59) |
| Mar 2026 | 24.9% | (1.50) |
| Dec 2025 | 26.4% | (0.55) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| AXGN AxoGen, Inc. compare | 74.2% |
| IRTC iRhythm Holdings, Inc. compare | 72.3% |
| TXG 10x Genomics compare | 70.0% |
| LIVN LivaNova PLC compare | 67.8% |
| HAE Haemonetics Corporation compare | 59.6% |
| TMDX TransMedics Group, Inc. compare | 58.6% |
| NEOG Neogen Corporation compare | 47.4% |
| UFPT UFP Technologies, Inc. compare | 29.0% |
| ITGR Integer Holdings Corporation | 24.6% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement